Back to
Aberdeen Group plc
MYGN5 quarters
Position history for
Aberdeen Group plc's holdings in MYRIAD GENETICS INC
Yes. Aberdeen Group holds 1,308,933 shares of MYGN (Myriad Genetics), worth $7.5M, as of its Q2 2026 13F filing. It increased the position by 198,529 shares (+17.9%) from Q1 2026. Aberdeen Group has held MYGN since Q2 2025, across 5 quarterly 13F filings.
Current Value
$7.5M
Current Shares
1.3M
Total Value Change
+$6.3M
Total Shares Change
+1.1M
Quarter-by-Quarter History
Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC